Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02984059 · ClinicalTrials.gov registry record

Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease

A clinical trial, sponsored by Connecticut Children's Medical Center.

Completed
Registry status
126
Enrollment target

NCT02984059 is a clinical trial that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 126 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02984059 has completed, sponsored by Connecticut Children's Medical Center.

COMPLETED
Registry status
126 participants
Enrollment target

Study Summary

To characterize persistent abdominal pain in children with inflammatory bowel disease (IBD) by examining factors such as disease type, activity and location, psychosocial factors, and genetics. The investigators hypothesize that by using patient pain and psychological assessments in addition to analysis of blood, stool and colonic biopsies, we can better characterize factors that predispose children and adolescents with IBD to have persistent and/or disproportionate abdominal pain.

Interventions

  • GENETIC RNA analysis
  • GENETIC Genomic DNA
  • GENETIC Microbiome
  • OTHER Calprotectin
  • OTHER Pain questionnaires

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2015-10-21
Est. Completion 2018-08-01

What the Registry Record Tells You About NCT02984059

The ClinicalTrials.gov registry entry for NCT02984059 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which RNA analysis is the first listed.

NCT02984059 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02984059 about?

NCT02984059 is a clinical study titled "Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease". To characterize persistent abdominal pain in children with inflammatory bowel disease (IBD) by examining factors such as disease type, activity and location, psychosocial factors, and genetics. The investigators hypothesize that by using patient pain and psychological assessments in addition to ana...

What is the current status of trial NCT02984059?

This trial is currently completed. The enrollment target is 126 participants. The study started on 2015-10-21. Estimated completion is 2018-08-01.

What interventions are being tested in trial NCT02984059?

The interventions under investigation include: RNA analysis (GENETIC), Genomic DNA (GENETIC), Microbiome (GENETIC), Calprotectin (OTHER), Pain questionnaires (OTHER).

Who is sponsoring clinical trial NCT02984059?

This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.